What is LOPJLB’s current signal on KYTX?

LOPJLB’s latest quantitative signal on Kyverna Therapeutics, Inc. (KYTX) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is KYTX in?

Kyverna Therapeutics, Inc. (KYTX) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Kyverna Therapeutics, Inc. (KYTX) do?

Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, and lupus nephritis, as well as multiple sclerosis and systemic sclerosis. The company is also deve…

Where is Kyverna Therapeutics, Inc. based / listed?

Kyverna Therapeutics, Inc. is based in US, listed on NASDAQ.

Kyverna Therapeutics, Inc. (KYTX)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$6.39+3.40%Close

SELLCRISIS · day 12

RANGE

DATA 2026-10-09

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $388M
Beta: 2.06
P/E (TTM): -2.10

Short % float: 34.94%
Days to cover: 8.8
SI change: +9.7%

1W: +2.73%
1M: -13.06%

vs SPY 1W: +1.57%
vs SPY 1M: -16.05%

Industry peers

FMP comparable companies · ranked by market cap

ALLOSELLAllogene Therapeutics, Inc.$504MCRISISQ -12$1.46+4.29%
CTNMSELLContineum Therapeutics, Inc.$503MRECOVERYQ 7$13.38+1.52%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Industry peers

Prediction markets

Company news